BSGM Public offering

BioSig Technologies Inc. Announces Proposed Public Offering

Published August 13, 2025 at 09:16 PM

Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”) which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM) today announced its intention to offer shares of common stock (or pre-funded warrants in lieu thereof) through an underwritten public offering. All of the shares of common stock (or pre-funded warrants in lieu thereof) are being offered by the Company. The completion of the offering remains subject to market conditions, with no assurance regarding its timing, size, or terms. The Company intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.

Related Questions

How will the proposed public offering affect BSGM's share price in the short and long term? What is the expected size and pricing range of the public offering? How will the issuance of common stock or pre‑funded warrants affect existing shareholders' dilution? What are the specific terms and conversion ratios for the pre‑funded warrants? When is the company targeting to close the offering and what are the key milestones? How will the proceeds allocated to gold bullion purchases impact the company's balance sheet and risk profile? What is the rationale behind using gold bullion as an investment, and how will it be accounted for? Which underwriters are involved and what is the anticipated level of demand for the shares? How does this offering compare in size and structure to recent capital raises by peer companies in the biotech/health‑tech sector? Will there be a lock‑up period for insiders and existing shareholders post‑offering? What impact is the offering likely to have on the stock's liquidity, bid‑ask spread, and short‑term price volatility? Are there any regulatory or shareholder approvals required before the offering can be completed? How will the additional capital for working capital and general corporate purposes be deployed to drive growth or improve profitability?